Eesti -
eesti -
Ravimiamet
dexamethason krka tablett
krka, d.d., novo mesto - deksametasoon - tablett - 40mg 50tk; 40mg 10tk; 40mg 30tk; 40mg 60tk; 40mg 100tk; 40mg 20tk
Eesti -
eesti -
Ravimiamet
metozok toimeainet prolongeeritult vabastav tablett
sandoz pharmaceuticals d.d. - metoprolool - toimeainet prolongeeritult vabastav tablett - 25mg 30tk
Eesti -
eesti -
Ravimiamet
metozok toimeainet prolongeeritult vabastav tablett
sandoz pharmaceuticals d.d. - metoprolool - toimeainet prolongeeritult vabastav tablett - 100mg 30tk
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - ravimid hingamisteede obstruktiivsete haiguste, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
Eesti -
eesti -
Ravimiamet
nodexon tablett
norameda uab - deksametasoon - tablett - 8mg 100tk; 8mg 50tk; 8mg 20tk
Eesti -
eesti -
Ravimiamet
nodexon tablett
norameda uab - deksametasoon - tablett - 4mg 30tk; 4mg 100tk; 4mg 20tk
Eesti -
eesti -
Ravimiamet
dexamethason krka tablett
lex ano uab - deksametasoon - tablett - 4mg 20tk
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
lupkynis
otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - immunosupressandid - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
vabysmo
roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - oftalmoloogilised vahendid - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).